Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1947 1
1950 1
1958 1
1962 1
1963 1
1971 1
1972 2
1973 1
1974 9
1975 5
1976 2
1977 3
1978 7
1979 1
1980 4
1981 2
1982 3
1983 5
1984 6
1985 5
1986 8
1987 2
1988 3
1989 2
1990 5
1991 7
1992 12
1993 6
1994 8
1995 10
1996 10
1997 3
1998 9
1999 4
2000 9
2001 7
2002 9
2003 10
2004 7
2005 11
2006 7
2007 3
2008 3
2009 2
2010 3
2011 5
2012 6
2013 6
2014 9
2015 9
2016 6
2017 5
2018 10
2019 12
2020 9
2021 9
2022 14
2023 10
2024 10
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

327 results

Results by year

Filters applied: . Clear all
Page 1
Viral croup: diagnosis and a treatment algorithm.
Petrocheilou A, Tanou K, Kalampouka E, Malakasioti G, Giannios C, Kaditis AG. Petrocheilou A, et al. Pediatr Pulmonol. 2014 May;49(5):421-9. doi: 10.1002/ppul.22993. Epub 2014 Mar 5. Pediatr Pulmonol. 2014. PMID: 24596395 Review.
A single dose of orally administered dexamethasone (0.15-0.6 mg/kg) is the mainstay of treatment with addition of nebulized epinephrine only in cases of moderate-to-severe croup. Nebulized budesonide (2 mg) can be given alternatively to children who do not tolerate oral de …
A single dose of orally administered dexamethasone (0.15-0.6 mg/kg) is the mainstay of treatment with addition of nebulized epinephrine …
Respiratory Syncytial Virus is the Most Common Causative Agent of Viral Bronchiolitis in Young Children: An Updated Review.
Hon KL, Leung AKC, Wong AHC, Dudi A, Leung KKY. Hon KL, et al. Curr Pediatr Rev. 2023;19(2):139-149. doi: 10.2174/1573396318666220810161945. Curr Pediatr Rev. 2023. PMID: 35950255 Review.
Beta-agonists are frequently used despite the lack of evidence that they reduce hospital admissions or length of stay. Nebulized racemic epinephrine, hypertonic saline and corticosteroids are generally not effective. ...
Beta-agonists are frequently used despite the lack of evidence that they reduce hospital admissions or length of stay. Nebulized racemic …
Nebulized racemic epinephrine for extubation of newborn infants.
Davies MW, Davis PG. Davies MW, et al. Cochrane Database Syst Rev. 2002;(1):CD000506. doi: 10.1002/14651858.CD000506. Cochrane Database Syst Rev. 2002. PMID: 11869578 Review.
MAIN RESULTS: No studies were identified which looked at the effect of inhaled nebulized epinephrine on clinically important outcomes in infants being extubated. IMPLICATIONS FOR PRACTICE: There is no evidence either supporting or refuting the use of inhaled nebulized r …
MAIN RESULTS: No studies were identified which looked at the effect of inhaled nebulized epinephrine on clinically important outcomes …
Nebulized racemic epinephrine for extubation of newborn infants.
Davies MW, Davis PG. Davies MW, et al. Cochrane Database Syst Rev. 2000;2002(2):CD000506. doi: 10.1002/14651858.CD000506. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2001;(1):CD000506. doi: 10.1002/14651858.CD000506. Update in: Cochrane Database Syst Rev. 2002;(1):CD000506. doi: 10.1002/14651858.CD000506. PMID: 10796376 Free PMC article. Updated. Review.
MAIN RESULTS: No studies were identified which looked at the effect of inhaled nebulised epinephrine on clinically important outcomes in infants being extubated. IMPLICATIONS FOR PRACTICE: There is no evidence either supporting or refuting the use of inhaled nebulised r …
MAIN RESULTS: No studies were identified which looked at the effect of inhaled nebulised epinephrine on clinically important outcomes …
Nebulized racemic epinephrine for extubation of newborn infants.
Davies MW, Davis PG. Davies MW, et al. Cochrane Database Syst Rev. 2001;(1):CD000506. doi: 10.1002/14651858.CD000506. Cochrane Database Syst Rev. 2001. PMID: 11279697 Review.
MAIN RESULTS: No studies were identified which looked at the effect of inhaled nebulised epinephrine on clinically important outcomes in infants being extubated. IMPLICATIONS FOR PRACTICE: There is no evidence either supporting or refuting the use of inhaled nebulised r …
MAIN RESULTS: No studies were identified which looked at the effect of inhaled nebulised epinephrine on clinically important outcomes …
Predictors of Inpatient Racemic Epinephrine Use in Patients Admitted With Croup.
Hancock WC, Scott M, Winer JC. Hancock WC, et al. Hosp Pediatr. 2023 Mar 1;13(3):258-264. doi: 10.1542/hpeds.2022-006870. Hosp Pediatr. 2023. PMID: 36751889
OBJECTIVE: Many patients hospitalized for croup receive no additional racemic epinephrine (RE) postadmission. We analyzed the association between inpatient racemic epinephrine (RE) use and demographic and emergency department (ED) parameters including …
OBJECTIVE: Many patients hospitalized for croup receive no additional racemic epinephrine (RE) postadmission. We analyzed the …
Nonprescription racemic epinephrine for asthma.
Mondal P, Kandala B, Ahrens R, Chesrown SE, Hendeles L. Mondal P, et al. J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):575-8. doi: 10.1016/j.jaip.2014.02.014. Epub 2014 Apr 18. J Allergy Clin Immunol Pract. 2014. PMID: 25213051 Clinical Trial.
BACKGROUND: Inhaled racepinephrine (RE) (Asthmanefrin) became available in September 2012 as a nonprescription treatment for bronchospasm based on a 1986 US Food and Drug Administration rule. ...Now that the product is promoted as a replacement for epinephrine chlor …
BACKGROUND: Inhaled racepinephrine (RE) (Asthmanefrin) became available in September 2012 as a nonprescription treatment for bronchos …
Decreasing Racemic Epinephrine for Bronchiolitis in an Academic Children's Hospital.
McCoy E, Chumpia M. McCoy E, et al. Hosp Pediatr. 2018 Oct;8(10):651-657. doi: 10.1542/hpeds.2017-0214. Hosp Pediatr. 2018. PMID: 30237259
Our aim was to decrease racemic epinephrine use for bronchiolitis by 50% within 8 months. METHODS: Our multidisciplinary team used the Institute for Healthcare Improvement's Model for Improvement to develop an aim statement, choose metrics, and perform plan-do-study …
Our aim was to decrease racemic epinephrine use for bronchiolitis by 50% within 8 months. METHODS: Our multidisciplinary team …
Inpatient use of racemic epinephrine for children admitted with croup.
Chiang E, Afandi O, Lee SH, Suresh S, Pitetti RD, Ramgopal S. Chiang E, et al. World J Pediatr. 2019 Dec;15(6):586-594. doi: 10.1007/s12519-019-00291-x. Epub 2019 Jul 25. World J Pediatr. 2019. PMID: 31342466
BACKGROUND: Pediatric patients with croup are frequently admitted if they require two doses of racemic epinephrine (RE) in the emergency department (ED). We aimed to identify factors associated with the need for additional therapy (> 2 RE doses) among pediatric p …
BACKGROUND: Pediatric patients with croup are frequently admitted if they require two doses of racemic epinephrine (RE) in the …
Epinephrine for transient tachypnea of the newborn.
Moresco L, Calevo MG, Baldi F, Cohen A, Bruschettini M. Moresco L, et al. Cochrane Database Syst Rev. 2016 May 23;2016(5):CD011877. doi: 10.1002/14651858.CD011877.pub2. Cochrane Database Syst Rev. 2016. PMID: 27211231 Free PMC article. Review.
Study authors administered three doses of nebulized 2.25% racemic epinephrine or placebo. We found no differences between the two group in the duration of supplemental oxygen therapy (mean difference (MD) -6.60, 95% confidence interval (CI) -54.80 to 41.60 hours) an …
Study authors administered three doses of nebulized 2.25% racemic epinephrine or placebo. We found no differences between the …
327 results